|
1
|
Liang YR, Liu C, Xiang LP and Zheng XQ:
Health benefits of theanine in green tea: A review. Trop J
Pharmaceut Res. 14:1943–1949. 2015. View Article : Google Scholar
|
|
2
|
Terashima T, Takido J and Yokogoshi H:
Time-dependent changes of amino acids in the serum, liver, brain
and urine of rats administered with theanine. Biosci Biotechnol
Biochem. 63:615–618. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Juneja LR, Chu DC, Okubo T, Nagato Y and
Yokogoshi H: L-theanine-a unique amino acid of green tea and its
relaxation effect in humans. Trends Food Sci Technol. 10:199–204.
1999. View Article : Google Scholar
|
|
4
|
Gomez-Ramirez M, Kelly SP, Montesi JL and
Foxe JJ: The effects of L-theanine on alpha-band oscillatory brain
activity during a visuo-spatial attention task. Brain Topogr.
22:44–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cho HS, Kim S, Lee SY, Park JA, Kim SJ and
Chun HS: Protective effect of the green tea component, L-theanine
on environmental toxins-induced neuronal cell death.
Neurotoxicology. 29:656–662. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bozzetti F, Biganzoli L, Gavazzi C,
Cappuzzo F, Carnaghi C, Buzzoni R, Dibartolomeo M and Baietta E:
Glutamine supplementation in cancer patients receiving
chemotherapy: A double-blind randomized study. Nutrition.
13:748–751. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yokogoshi H and Kobayashi M: Hypotensive
effect of gamma-glutamylmethylamide in spontaneously hypertensive
rats. Life Sci. 62:1065–1068. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang G, Ye X, Ji D, Zhang H, Sun F, Shang
C, Zhang Y, Wu E, Wang F, Wu F, et al: Inhibition of lung tumor
growth by targeting EGFR/VEGFR-Akt/NF-κB pathways with novel
theanine derivatives. Oncotarget. 5:8528–8543. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martin KR: Targeting apoptosis with
dietary bioactive agents. Exp Biol Med (Maywood). 231:117–129.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakazato T, Ito K, Miyakawa Y, Kinjo K,
Yamada T, Hozumi N, Ikeda Y and Kizaki M: Catechin, a green tea
component, rapidly induces apoptosis of myeloid leukemic cells via
modulation of reactive oxygen species production in vitro and
inhibits tumor growth in vivo. Haematologica. 90:317–325.
2005.PubMed/NCBI
|
|
11
|
Yang GY, Liao J, Kim K, Yurkow EJ and Yang
CS: Inhibition of growth and induction of apoptosis in human cancer
cell lines by tea polyphenols. Carcinogenesis. 19:611–616. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kundu T, Dey S, Roy M, Siddiqi M and
Bhattacharya RK: Induction of apoptosis in human leukemia cells by
black tea and its polyphenol theaflavin. Cancer Lett. 230:111–121.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang G, Miura Y and Yagasaki K:
Inhibitory effects of theanine and sera from theanine-fed rats on
receptor-mediated cancer cell invasion beneath mesothelial-cell
monolayers. Cytotechnology. 36:195–200. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Q, Duan H, Luan J, Yagasaki K and
Zhang G: Effects of theanine on growth of human lung cancer and
leukemia cells as well as migration and invasion of human lung
cancer cells. Cytotechnology. 59:211–217. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sugiyama T and Sadzuka Y: Theanine, a
specific glutamate derivative in green tea, reduces the adverse
reactions of doxorubicin by changing the glutathione level. Cancer
Lett. 212:177–184. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kakuda T, Hinoi E, Abe A, Nozawa A, Ogura
M and Yoneda Y: Theanine, an ingredient of green tea, inhibits
[3H]glutamine transport in neurons and astroglia in rat brain. J
Neurosci Res. 86:1846–1856. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Friedman M, Mackey BE, Kim HJ, Lee IS, Lee
KR, Lee SU, Kozukue E and Kozukue N: Structure-activity
relationships of tea compounds against human cancer cells. J Agric
Food Chem. 55:243–253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi Y: Mechanisms of caspase activation
and inhibition during apoptosis. Mol Cell. 9:459–470. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kroemer G, Galluzzi L and Brenner C:
Mitochondrial membrane permeabilization in cell death. Physiol Rev.
87:99–163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kerr SH and Kerr DJ: Novel treatments for
hepatocellular cancer. Cancer Lett. 286:114–120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kuhn KS, Muscaritoli M, Wischmeyer P and
Stehle P: Glutamine as indispensable nutrient in oncology:
Experimental and clinical evidence. Eur J Nutr. 49:197–210. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sadzuka Y, Sugiyama T, Nagamine M, Umegaki
K and Sonobe T: Efficacy of theanine is connected with theanine
metabolism by any enzyme, not only drug metabolizing enzymes. Food
Chem Toxicol. 44:286–292. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shanware NP, Mullen AR, DeBerardinis RJ
and Abraham RT: Glutamine: Pleiotropic roles in tumor growth and
stress resistance. J Mol Med (Berl). 89:229–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tardito S, Chiu M, Uggeri J, Zerbini A, Da
Ros F, Dall'Asta V, Missale G and Bussolati O: L-Asparaginase and
inhibitors of glutamine synthetase disclose glutamine addiction of
β-catenin-mutated human hepatocellular carcinoma cells. Curr Cancer
Drug Targets. 11:929–943. 2011. View Article : Google Scholar : PubMed/NCBI
|
